<p>Each box indicates the values from 25° to 75° percentile (interquartile range), the horizontal lines represent the median value of weekly warfarin dose, the maximum length of whisker is 1.5 fold the interquartile range. * p<0.05, ** p<0.001at ANOVA test.</p
<p>Mean and median warfarin dose increased as WRI increased. WR 0, WRI 1 and WRI 2 classes are as sp...
What is known and Objectives: Testing for cytochrome P450-2C9 (CYP2C9) and vitamin K epoxide reduct...
CYP2C9 and VKORC1 genotypes predict therapeutic warfarin dose at initiation of therapy; however, the...
<p>Each box indicates the values from 25° to 75° percentile (interquartile range), the white lines r...
<p>Each box indicates the 25th to 75th percentile values (interquartile range); the black lines repr...
<p>* represented the comparison of actual stable wafarin dose in different genotypes for the gene po...
<p>The solid line represent a good correlation between the two doses. Open circles represent individ...
<p>(A) Box-and-whisker plots of <i>S</i>-warfarin plasma concentration and INR on days 7/8/9 segrega...
AIM: A total of 371 patients under stable warfarin therapy were retrospectively selected to develop ...
Aim: A total of 371 patients under stable warfarin therapy were retrospectively selected to develop ...
The objective of the study was to update a previous NONMEM model to describe the relationship betwee...
Polymorphisms in CYP 2C9 and VKOR C1 have been shown to be associated with warfarin dose requirement...
Pētījuma mērķis. Novērtēt varfarīna farmakoģenētiska testa prognozēto devu atbilstību pacientu fakti...
Background: The aim of this study is to assess the accuracy of warfarin dosage based on VKORC1 and C...
Aim: To evaluate applicability of CYP2C9* 2,* 3 and VKORC1–1639G> A based algorithm to predict warfa...
<p>Mean and median warfarin dose increased as WRI increased. WR 0, WRI 1 and WRI 2 classes are as sp...
What is known and Objectives: Testing for cytochrome P450-2C9 (CYP2C9) and vitamin K epoxide reduct...
CYP2C9 and VKORC1 genotypes predict therapeutic warfarin dose at initiation of therapy; however, the...
<p>Each box indicates the values from 25° to 75° percentile (interquartile range), the white lines r...
<p>Each box indicates the 25th to 75th percentile values (interquartile range); the black lines repr...
<p>* represented the comparison of actual stable wafarin dose in different genotypes for the gene po...
<p>The solid line represent a good correlation between the two doses. Open circles represent individ...
<p>(A) Box-and-whisker plots of <i>S</i>-warfarin plasma concentration and INR on days 7/8/9 segrega...
AIM: A total of 371 patients under stable warfarin therapy were retrospectively selected to develop ...
Aim: A total of 371 patients under stable warfarin therapy were retrospectively selected to develop ...
The objective of the study was to update a previous NONMEM model to describe the relationship betwee...
Polymorphisms in CYP 2C9 and VKOR C1 have been shown to be associated with warfarin dose requirement...
Pētījuma mērķis. Novērtēt varfarīna farmakoģenētiska testa prognozēto devu atbilstību pacientu fakti...
Background: The aim of this study is to assess the accuracy of warfarin dosage based on VKORC1 and C...
Aim: To evaluate applicability of CYP2C9* 2,* 3 and VKORC1–1639G> A based algorithm to predict warfa...
<p>Mean and median warfarin dose increased as WRI increased. WR 0, WRI 1 and WRI 2 classes are as sp...
What is known and Objectives: Testing for cytochrome P450-2C9 (CYP2C9) and vitamin K epoxide reduct...
CYP2C9 and VKORC1 genotypes predict therapeutic warfarin dose at initiation of therapy; however, the...